4 September 2015
2015 JAD Editorial Board Meeting
On July 20, 2015, JAD Editor-in-Chief George Perry, PhD, presented statistics and policies related to the Journal of Alzheimer’s Disease, including its new website developments. The presentation is published here for all JAD editors and readers to view. Over 90 Editorial Board members attended the meeting.
24 August 2015
Waterford research on Alzheimer’s disease suggests that measuring macular pigment offers potential as a biomarker of cognitive health
Ongoing European Research Council-funded research at Waterford Institute of Technology’s (WIT) Macular Pigment Research Group (MPRG) is investigating the potential link between cognitive function and levels of a vital eye pigment linked to diet. The study suggests that measuring macular pigment offers potential as a biomarker of cognitive health.
5 August 2015
Insulin’s potential to treat dementia outlined in new study: Researchers showed how insulin reaches and acts in the brain to mitigate memory loss
Researchers at the UW Medicine, Veteran's Administration Puget Sound and Saint Louis University have made a promising discovery that insulin delivered high up in the nasal cavity goes to affected areas of brain with lasting results in improving memory.
28 July 2015
Coffee Consumption Habits Impact the Risk of Mild Cognitive Impairment: The Italian Longitudinal Study on Aging
A new study estimates the association between change or constant habits in coffee consumption and the incidence of mild cognitive impairment, evaluating 1,445 individuals recruited from 5,632 subjects, aged 65-84 year old, from the Italian Longitudinal Study on Aging, a population-based sample from eight Italian municipalities with a 3.5-year median follow-up.
22 July 2015
New Study Indicates Ankle-Brachial Index Associated with Mild Cognitive Impairment
In a large population-based study of randomly selected participants in Germany, researchers found that mild cognitive impairment occurred significantly more often in individuals diagnosed with a lower ankle brachial index, which is a marker of generalized atherosclerosis and thus cumulative exposure to cardiovascular risk factors during lifetime.
16 July 2015
Midlife High Blood Pressure May Negatively Impact the Brain Years Later
Having high blood pressure in your 50’s may impact your ability to keep track or plan ahead in your 80’s. This study reports a connection between high blood pressure at a younger age can affect cognition many years later. It currently appears in the Journal of Alzheimer’s Disease.
14 July 2015
Alzheimer's Disease Prevention: New Journal Article Highlights Benefits of Meditation and Spiritual Fitness
Meditation and spiritual fitness are key components in reducing the risk of Alzheimer’s disease according to a new article, “Stress, Meditation, and Alzheimer’s Prevention: Where the Evidence Stands”, published in an early online version of the Journal of Alzheimer’s Disease 48(1).
14 July 2015
Affordable, Non-Invasive Test May Detect Who is Most at Risk for Alzheimer's
Individuals with amnestic mild cognitive impairment (aMCI) are at twice the risk of others in their age group of progressing to Alzheimer’s disease. Although no conclusive test exists to predict who will develop Alzheimer’s, new research from the Center for BrainHealth at The University of Texas at Dallas is attempting to identify a potential biomarker that could offer a more complete picture of who is most at risk.
26 June 2015
Hartmuth Kolb, PhD, Wins 2015 Alzheimer Award
The Journal of Alzheimer’s Disease is proud to announce that Hartmuth Kolb, PhD, Head of Neuroscience Biomarkers, Johnson & Johnson, San Diego, CA, has been chosen as the recipient of the 2015 Alzheimer Award presented by the Journal of Alzheimer’s Disease in recognition of his outstanding work on the importance and imaging of neurofibrillary tangles and Alzheimer’s disease.
24 June 2015
Multiple Pathways Progressing to Alzheimer’s Disease
The amyloid cascade hypothesis of Alzheimer’s disease (AD) posits that sticky aggregations or plaques of amyloid-beta peptides accumulate over time in the brain, triggering a series of events that ultimately result in the full-blown neurodegenerative disorder. However, in a new study published in JAD, researchers at University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System suggest the picture is not so clear-cut, reporting that early indicators or biomarkers of AD development are not fixed in a specific sequence.